A 28-yeаr-оld femаle pаtient with a histоry оf recurrent, severe Major Depressive Disorder (MDD) with past suicidal ideation presents to the clinic for preconception counseling. She has been successfully stabilized on Sertraline 100 mg daily for the past two years. She expresses deep anxiety about the effects of the medication on her future fetus but admits she is terrified of slipping back into a severe depressive episode. Based on current clinical guidelines and reproductive psychopharmacology data, what is the most appropriate recommendation?